RATIONALE: Conventionally, myofibrillar protein synthesis is measured over time periods of hours. In clinical studies, interventions occur over weeks. Functional measures over such periods may be more representative. We aimed to develop a novel method to determine myofibrillar protein fractional synthetic rate (FSR) to estimate habitual rates, while avoiding intravenous tracer infusions. METHODS: Four healthy males were given 100 g water enriched to 70 Atom % with (2)H2O as a single oral bolus. Vastus-lateralis needle biopsies were performed and plasma samples collected, 3-13 days post-dose. (2)H enrichment in body water was measured in plasma using continuous flow isotope ratio mass spectrometry (IRMS). Myofibrillar protein was isolated from muscle biopsies and acid hydrolysed. (2)H enrichment of protein-bound and plasma-free alanine was measured by gas chromatography (GC)/pyrolysis/IRMS. Myofibrillar protein FSR was calculated (% day(-1)). RESULTS: The tracer bolus raised the initial enrichment of body water to 1514 ppm (2)H excess. Water elimination followed a simple exponential. The average elimination half-time was 8.3 days. Plasma alanine, labelled during de novo synthesis, followed the same elimination kinetics as water. The weighted average myofibrillar protein FSR from the four subjects was 1.38 % day(-1) (range, 1.0-1.9 % day(-1) ). CONCLUSIONS: Myofibrillar protein FSR was measured in free-living healthy individuals over 3-13 days. Using a single oral (2)H2O bolus, endogenous labelling of alanine occurred in a predictable manner giving estimates of synthesis comparable with published values. Furthermore, the protocol does not compromise the ability to measure other important metabolic processes such as total energy expenditure.
RATIONALE: Conventionally, myofibrillar protein synthesis is measured over time periods of hours. In clinical studies, interventions occur over weeks. Functional measures over such periods may be more representative. We aimed to develop a novel method to determine myofibrillar protein fractional synthetic rate (FSR) to estimate habitual rates, while avoiding intravenous tracer infusions. METHODS: Four healthy males were given 100 g water enriched to 70 Atom % with (2)H2O as a single oral bolus. Vastus-lateralis needle biopsies were performed and plasma samples collected, 3-13 days post-dose. (2)H enrichment in body water was measured in plasma using continuous flow isotope ratio mass spectrometry (IRMS). Myofibrillar protein was isolated from muscle biopsies and acid hydrolysed. (2)H enrichment of protein-bound and plasma-free alanine was measured by gas chromatography (GC)/pyrolysis/IRMS. Myofibrillar protein FSR was calculated (% day(-1)). RESULTS: The tracer bolus raised the initial enrichment of body water to 1514 ppm (2)H excess. Water elimination followed a simple exponential. The average elimination half-time was 8.3 days. Plasma alanine, labelled during de novo synthesis, followed the same elimination kinetics as water. The weighted average myofibrillar protein FSR from the four subjects was 1.38 % day(-1) (range, 1.0-1.9 % day(-1) ). CONCLUSIONS: Myofibrillar protein FSR was measured in free-living healthy individuals over 3-13 days. Using a single oral (2)H2O bolus, endogenous labelling of alanine occurred in a predictable manner giving estimates of synthesis comparable with published values. Furthermore, the protocol does not compromise the ability to measure other important metabolic processes such as total energy expenditure.
Authors: Ross N Butler; Margaret Kosek; Nancy F Krebs; Cornelia U Loechl; Alexander Loy; Victor O Owino; Michael B Zimmermann; Douglas J Morrison Journal: J Pediatr Gastroenterol Nutr Date: 2017-01 Impact factor: 2.839
Authors: Sara Y Oikawa; Michael J Kamal; Erin K Webb; Chris McGlory; Steven K Baker; Stuart M Phillips Journal: Am J Clin Nutr Date: 2020-03-01 Impact factor: 7.045
Authors: Felipe Damas; Stuart M Phillips; Cleiton A Libardi; Felipe C Vechin; Manoel E Lixandrão; Paulo R Jannig; Luiz A R Costa; Aline V Bacurau; Tim Snijders; Gianni Parise; Valmor Tricoli; Hamilton Roschel; Carlos Ugrinowitsch Journal: J Physiol Date: 2016-07-09 Impact factor: 5.182
Authors: Daniel J Wilkinson; Martino V Franchi; Matthew S Brook; Marco V Narici; John P Williams; William K Mitchell; Nathaniel J Szewczyk; Paul L Greenhaff; Philip J Atherton; Kenneth Smith Journal: Am J Physiol Endocrinol Metab Date: 2013-12-31 Impact factor: 4.310
Authors: Daniel J Wilkinson; Jessica Cegielski; Bethan E Phillips; Catherine Boereboom; Jonathan N Lund; Philip J Atherton; Kenneth Smith Journal: Physiol Rep Date: 2015-07
Authors: M S Brook; D J Wilkinson; B E Phillips; J Perez-Schindler; A Philp; K Smith; P J Atherton Journal: Acta Physiol (Oxf) Date: 2015-06-21 Impact factor: 6.311